ADC Therapeutics SA
ADC Therapeutics SA
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||
Assets Current | |||||||||||||||
Cash And Cash Equivalents At Carrying Value | 231 | 261 | 235 | 265 | 195 | 251 | 274 | 300 | 234 | 279 | |||||
Accounts And Other Receivables Net Current | 31 | 29 | 23 | 26 | 32 | 20 | 24 | 23 | 23 | 25 | |||||
Inventory Net | 5 | 4 | 18 | 18 | 17 | 2 | 16 | 15 | 16 | 16 | |||||
Prepaid Expense And Other Assets Current | 6 | 6 | 6 | 5 | 7 | 8 | 19 | 17 | 17 | 10 | |||||
Other Assets Current | 4 | 6 | 6 | 6 | 7 | 9 | - | - | - | 6 | |||||
Assets Current | 277 | 306 | 287 | 319 | 258 | 291 | 333 | 355 | 290 | 336 | |||||
Inventory Noncurrent | 12 | 14 | - | - | - | 16 | - | - | - | - | |||||
Property Plant And Equipment Net | - | 0 | 0 | 0 | 5 | 5 | 6 | 5 | 6 | 6 | |||||
Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 8 | 8 | 9 | 10 | 10 | 11 | |||||
Equity Method Investments | - | - | - | - | - | 0 | 0 | 0 | 1 | 2 | |||||
Deferred Income Tax Assets Net | - | - | - | - | - | - | - | - | - | 0 | |||||
Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Assets | 291 | 323 | 290 | 322 | 273 | 322 | 349 | 372 | 308 | 355 | |||||
Liabilities And Stockhold… | |||||||||||||||
Liabilities Current | |||||||||||||||
Accounts Payable Current | 5 | 9 | 8 | 10 | 16 | 18 | 14 | 11 | 14 | 16 | |||||
Accrued Liabilities Current | 58 | 58 | 54 | 55 | 42 | 62 | 53 | 47 | 49 | 52 | |||||
Operating Lease Liability Current | - | - | - | - | - | - | - | - | - | 1 | |||||
Long Term Debt Current | 5 | 3 | - | - | - | 0 | - | - | - | - | |||||
Liabilities Current | 68 | 70 | 62 | 65 | 58 | 80 | 68 | 58 | 63 | 68 | |||||
Secured Long Term Debt | 111 | 112 | 115 | 114 | 114 | 114 | 114 | 114 | 113 | 113 | |||||
Warrants And Rights Outstanding | 19 | - | - | - | - | - | - | - | - | - | |||||
Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 8 | 8 | 9 | 9 | 10 | 10 | |||||
Other Liabilities Noncurrent | 5 | 3 | 9 | 7 | 4 | 2 | 8 | 7 | 7 | 9 | |||||
Liabilities | 508 | 509 | 528 | 521 | 511 | 525 | 521 | 503 | 502 | 503 | |||||
Stockholders Equity Inclu… | |||||||||||||||
Common Stock Value | 11 | 11 | 10 | 10 | 8 | 8 | 8 | 8 | 7 | 7 | |||||
Additional Paid In Capital | 1,442 | 1,440 | 1,382 | 1,380 | 1,287 | 1,284 | 1,282 | 1,279 | 1,181 | 1,181 | |||||
Treasury Stock Value | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1 | -1 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -1 | -1 | -1 | -0 | -1 | -1 | 0 | -0 | -0 | -0 | |||||
Retained Earnings Accumulated Deficit | -1,669 | -1,636 | -1,630 | -1,589 | -1,532 | -1,493 | -1,463 | -1,419 | -1,382 | -1,335 | |||||
Stockholders Equity | -216 | -186 | -238 | -199 | -238 | -203 | -172 | -132 | -194 | -148 | |||||
Liabilities And Stockholders Equity | 291 | 323 | 290 | 322 | 273 | 322 | 349 | 372 | 308 | 355 | |||||
Common Stock Par Or Stated Value Per Share | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | |||||
Common Stock Shares Issued | 130 | 128 | 115 | 115 | 102 | 102 | 99 | 99 | 89 | 89 | |||||
Shares Outstanding | 127 | 126 | 113 | 112 | 99 | 99 | 97 | 96 | 83 | 82 | |||||
Treasury Stock Common Shares | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 6 | 7 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -7.61% | -72.28% | -68.75% | - | - | - | - | - | - | - | - | - |
| 2025 | 102.76% | 57.46% | 48.62% | 20.41% | 38.78% | 51.70% | -21.85% | -16.39% | -14.25% | -21.25% | -20.21% | -29.17% |
| 2024 | -22.92% | -28.99% | -18.43% | -0.68% | 5.48% | 1.03% | -17.41% | -30.72% | -39.59% | -20.39% | 24.34% | 135.53% |
| 2023 | - | - | - | - | - | - | - | - | - | 28.21% | 25.64% | -12.05% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
ADC Therapeutics SA (ADCT) — SEC Financial Statements & Analysis
ADC Therapeutics SA (ADCT) is a pharmaceutical preparations company, incorporated in V8. ADC Therapeutics SA trades on NYSE as: ADCT. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), ADC Therapeutics SA reported a 20.82% year-over-year revenue growth, a Debt-to-Equity ratio of -2.35x, a Price-to-Sales (P/S) ratio of 6.82x (TTM), a Price-to-Book (P/B) ratio of -2.67 (TTM), at a market cap of $578.03M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 20.82%
- Debt To Equity
- -2.35x
- P/S TTM
- 6.82x
- P/B TTM
- -2.67
- Market Cap
- $578.03M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ADC Therapeutics SA in?
ADC Therapeutics SA (ADCT) operates in the Pharmaceutical Preparations industry.
What is ADCT's market cap?
ADC Therapeutics SA (ADCT) has a market capitalization of $578.03M as of 2026-03-31.
What exchange does ADCT trade on?
ADC Therapeutics SA (ADCT) trades on the NYSE.
Where is ADC Therapeutics SA incorporated?
ADC Therapeutics SA is incorporated in Switzerland.